Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Supplementation with the Sialic Acid Precursor N-acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.

Peng J, Vongpatanasin W, Sacharidou A, Kifer D, Yuhanna IS, Banerjee S, Tanigaki K, Polasek O, Chu H, Sundgren NC, Rohatgi A, Chambliss KL, Lauc G, Mineo C, Shaul PW.

Circulation. 2019 Oct 10. doi: 10.1161/CIRCULATIONAHA.119.043490. [Epub ahead of print]

PMID:
31597453
2.

SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.

Huang L, Chambliss KL, Gao X, Yuhanna IS, Behling-Kelly E, Bergaya S, Ahmed M, Michaely P, Luby-Phelps K, Darehshouri A, Xu L, Fisher EA, Ge WP, Mineo C, Shaul PW.

Nature. 2019 May;569(7757):565-569. doi: 10.1038/s41586-019-1140-4. Epub 2019 Apr 24.

PMID:
31019307
3.

Selective Nonnuclear Estrogen Receptor Activation Decreases Stroke Severity and Promotes Functional Recovery in Female Mice.

Selvaraj UM, Zuurbier KR, Whoolery CW, Plautz EJ, Chambliss KL, Kong X, Zhang S, Kim SH, Katzenellenbogen BS, Katzenellenbogen JA, Mineo C, Shaul PW, Stowe AM.

Endocrinology. 2018 Nov 1;159(11):3848-3859. doi: 10.1210/en.2018-00600.

PMID:
30256928
4.

Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium.

Sacharidou A, Chambliss KL, Ulrich V, Salmon JE, Shen YM, Herz J, Hui DY, Terada LS, Shaul PW, Mineo C.

Blood. 2018 May 10;131(19):2097-2110. doi: 10.1182/blood-2017-11-814681. Epub 2018 Mar 2.

5.

Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance.

Tanigaki K, Sacharidou A, Peng J, Chambliss KL, Yuhanna IS, Ghosh D, Ahmed M, Szalai AJ, Vongpatanasin W, Mattrey RF, Chen Q, Azadi P, Lingvay I, Botto M, Holland WL, Kohler JJ, Sirsi SR, Hoyt K, Shaul PW, Mineo C.

J Clin Invest. 2018 Jan 2;128(1):309-322. doi: 10.1172/JCI89333. Epub 2017 Nov 27.

6.

Non-nuclear estrogen receptor alpha activation in endothelium reduces cardiac ischemia-reperfusion injury in mice.

Menazza S, Sun J, Appachi S, Chambliss KL, Kim SH, Aponte A, Khan S, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW, Murphy E.

J Mol Cell Cardiol. 2017 Jun;107:41-51. doi: 10.1016/j.yjmcc.2017.04.004. Epub 2017 Apr 27.

7.

Nonnuclear Estrogen Receptor Activation Improves Hepatic Steatosis in Female Mice.

Chambliss KL, Barrera J, Umetani M, Umetani J, Kim SH, Madak-Erdogan Z, Huang L, Katzenellenbogen BS, Katzenellenbogen JA, Mineo C, Shaul PW.

Endocrinology. 2016 Oct;157(10):3731-3741. Epub 2016 Aug 23.

8.

Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues.

Madak-Erdogan Z, Kim SH, Gong P, Zhao YC, Zhang H, Chambliss KL, Carlson KE, Mayne CG, Shaul PW, Korach KS, Katzenellenbogen JA, Katzenellenbogen BS.

Sci Signal. 2016 May 24;9(429):ra53. doi: 10.1126/scisignal.aad8170.

9.

Endothelial Fcγ Receptor IIB Activation Blunts Insulin Delivery to Skeletal Muscle to Cause Insulin Resistance in Mice.

Tanigaki K, Chambliss KL, Yuhanna IS, Sacharidou A, Ahmed M, Atochin DN, Huang PL, Shaul PW, Mineo C.

Diabetes. 2016 Jul;65(7):1996-2005. doi: 10.2337/db15-1605. Epub 2016 Apr 26.

10.

IgG receptor FcγRIIB plays a key role in obesity-induced hypertension.

Sundgren NC, Vongpatanasin W, Boggan BM, Tanigaki K, Yuhanna IS, Chambliss KL, Mineo C, Shaul PW.

Hypertension. 2015 Feb;65(2):456-62. doi: 10.1161/HYPERTENSIONAHA.114.04670. Epub 2014 Nov 3.

11.

Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.

Barrera J, Chambliss KL, Ahmed M, Tanigaki K, Thompson B, McDonald JG, Mineo C, Shaul PW.

Am J Physiol Endocrinol Metab. 2014 Aug 1;307(3):E345-54. doi: 10.1152/ajpendo.00653.2013. Epub 2014 Jun 17.

12.

Recent insights into non-nuclear actions of estrogen receptor alpha.

Banerjee S, Chambliss KL, Mineo C, Shaul PW.

Steroids. 2014 Mar;81:64-9. doi: 10.1016/j.steroids.2013.11.002. Epub 2013 Nov 16. Review.

PMID:
24252382
13.

Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass.

Bartell SM, Han L, Kim HN, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS, Chambliss KL, Shaul PW, Roberson PK, Weinstein RS, Jilka RL, Almeida M, Manolagas SC.

Mol Endocrinol. 2013 Apr;27(4):649-56. doi: 10.1210/me.2012-1368. Epub 2013 Feb 26.

14.

Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function.

Sundgren NC, Zhu W, Yuhanna IS, Chambliss KL, Ahmed M, Tanigaki K, Umetani M, Mineo C, Shaul PW.

Circ Res. 2011 Oct 28;109(10):1132-40. doi: 10.1161/CIRCRESAHA.111.254573. Epub 2011 Sep 22.

15.

Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.

Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW.

J Clin Invest. 2010 Jul;120(7):2319-30. doi: 10.1172/JCI38291. Epub 2010 Jun 23.

16.

C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Tanigaki K, Mineo C, Yuhanna IS, Chambliss KL, Quon MJ, Bonvini E, Shaul PW.

Circ Res. 2009 Jun 5;104(11):1275-82. doi: 10.1161/CIRCRESAHA.108.192906. Epub 2009 May 7.

17.

The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.

Zhu W, Saddar S, Seetharam D, Chambliss KL, Longoria C, Silver DL, Yuhanna IS, Shaul PW, Mineo C.

Circ Res. 2008 Feb 29;102(4):480-7. doi: 10.1161/CIRCRESAHA.107.159079. Epub 2008 Jan 3.

PMID:
18174467
18.

Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α .

Kumar P, Wu Q, Chambliss KL, Yuhanna IS, Mumby SM, Mineo C, Tall GG, Shaul PW.

Mol Endocrinol. 2007 Jun;21(6):1370-80. Epub 2007 Apr 3.

PMID:
17405905
19.

High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I.

Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens RL, Marcel YL, Rader DJ, Shaul PW.

Circ Res. 2006 Jan 6;98(1):63-72. Epub 2005 Dec 8.

PMID:
16339487
20.

Molecular basis of estrogen-induced cyclooxygenase type 1 upregulation in endothelial cells.

Gibson LL, Hahner L, Osborne-Lawrence S, German Z, Wu KK, Chambliss KL, Shaul PW.

Circ Res. 2005 Mar 18;96(5):518-25. Epub 2005 Feb 10.

PMID:
15705965
21.

Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERalpha domains with known nuclear functions.

Chambliss KL, Simon L, Yuhanna IS, Mineo C, Shaul PW.

Mol Endocrinol. 2005 Feb;19(2):277-89. Epub 2004 Oct 14.

PMID:
15486047
22.

Estrogen causes dynamic alterations in endothelial estrogen receptor expression.

Ihionkhan CE, Chambliss KL, Gibson LL, Hahner LD, Mendelsohn ME, Shaul PW.

Circ Res. 2002 Nov 1;91(9):814-20.

PMID:
12411396
23.

Estrogen modulation of endothelial nitric oxide synthase.

Chambliss KL, Shaul PW.

Endocr Rev. 2002 Oct;23(5):665-86. Review.

PMID:
12372846
24.

ERbeta has nongenomic action in caveolae.

Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW.

Mol Endocrinol. 2002 May;16(5):938-46.

PMID:
11981029
25.

Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium.

Sherman TS, Chambliss KL, Gibson LL, Pace MC, Mendelsohn ME, Pfister SL, Shaul PW.

Am J Respir Cell Mol Biol. 2002 May;26(5):610-6.

PMID:
11970914
26.
27.

Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i).

Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW.

J Biol Chem. 2001 Jul 20;276(29):27071-6. Epub 2001 May 21.

28.

Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae.

Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW.

Circ Res. 2000 Nov 24;87(11):E44-52.

PMID:
11090554
29.

Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency.

Chambliss KL, Gray RG, Rylance G, Pollitt RJ, Gibson KM.

J Inherit Metab Dis. 2000 Jul;23(5):497-504.

PMID:
10947204
30.

Molecular basis of cell-specific endothelial nitric-oxide synthase expression in airway epithelium.

German Z, Chambliss KL, Pace MC, Arnet UA, Lowenstein CJ, Shaul PW.

J Biol Chem. 2000 Mar 17;275(11):8183-9.

31.

Establishment of an immortalized fetal intrapulmonary artery endothelial cell line.

Pace MC, Chambliss KL, German Z, Yuhanna IS, Mendelsohn ME, Shaul PW.

Am J Physiol. 1999 Jul;277(1):L106-12. doi: 10.1152/ajplung.1999.277.1.L106.

PMID:
10409236
32.

Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting.

Olivier LM, Chambliss KL, Gibson KM, Krisans SK.

J Lipid Res. 1999 Apr;40(4):672-9.

33.

Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria).

Chambliss KL, Hinson DD, Trettel F, Malaspina P, Novelletto A, Jakobs C, Gibson KM.

Am J Hum Genet. 1998 Aug;63(2):399-408.

34.

Characterization of the mevalonate kinase 5'-untranslated region provides evidence for coordinate regulation of cholesterol biosynthesis.

Bishop RW, Chambliss KL, Hoffmann GF, Tanaka RD, Gibson KM.

Biochem Biophys Res Commun. 1998 Jan 26;242(3):518-24.

PMID:
9464248
35.

Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways.

Hinson DD, Chambliss KL, Toth MJ, Tanaka RD, Gibson KM.

J Lipid Res. 1997 Nov;38(11):2216-23.

36.

Identification of an active site alanine in mevalonate kinase through characterization of a novel mutation in mevalonate kinase deficiency.

Hinson DD, Chambliss KL, Hoffmann GF, Krisans S, Keller RK, Gibson KM.

J Biol Chem. 1997 Oct 17;272(42):26756-60.

37.

Mevalonate kinase map position 12q24.

Gibson KM, Hoffmann GF, Tanaka RD, Bishop RW, Chambliss KL.

Chromosome Res. 1997 Apr;5(2):150. No abstract available.

PMID:
9146921
38.

Human succinic semialdehyde dehydrogenase. Molecular cloning and chromosomal localization.

Trettel F, Malaspina P, Jodice C, Novelletto A, Slaughter CA, Caudle DL, Hinson DD, Chambliss KL, Gibson KM.

Adv Exp Med Biol. 1997;414:253-60. No abstract available.

PMID:
9059628
39.

Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence.

Chambliss KL, Slaughter CA, Schreiner R, Hoffmann GF, Gibson KM.

J Biol Chem. 1996 Jul 19;271(29):17330-4.

40.

Enzymatic and immunologic identification of succinic semialdehyde dehydrogenase in rat and human neural and nonneural tissues.

Chambliss KL, Zhang YA, Rossier E, Vollmer B, Gibson KM.

J Neurochem. 1995 Aug;65(2):851-5.

PMID:
7616245
41.

Molecular cloning of the mature NAD(+)-dependent succinic semialdehyde dehydrogenase from rat and human. cDNA isolation, evolutionary homology, and tissue expression.

Chambliss KL, Caudle DL, Hinson DD, Moomaw CR, Slaughter CA, Jakobs C, Gibson KM.

J Biol Chem. 1995 Jan 6;270(1):461-7.

42.

Enzymatic and immunological demonstration of normal and defective succinic semialdehyde dehydrogenase activity in fetal brain, liver and kidney.

Chambliss KL, Lee CF, Ogier H, Rabier D, Jakobs C, Gibson KM.

J Inherit Metab Dis. 1993;16(3):523-6. No abstract available.

PMID:
7609442
43.
44.

4-Hydroxybutyric aciduria: application of a fluorometric assay to the determination of succinic semialdehyde dehydrogenase activity in extracts of cultured human lymphoblasts.

Gibson KM, Lee CF, Chambliss KL, Kamali V, Francois B, Jaeken J, Jakobs C.

Clin Chim Acta. 1991 Feb 15;196(2-3):219-21. No abstract available.

PMID:
2029787

Supplemental Content

Loading ...
Support Center